Worth Seeing!
Invest in Cases Systematically - Every stock is handpicked Start Buying Now Start Buying Now
mw4me logo
Talk to Us | Subscribe | Advisory Services

Top Pharma Companies in India by Market Capitalisation - Identify Top Performing Pharmaceutical Sector Companies for Investment Today

Sensex 74005.94
88.91 (0.12%)

Pharma Sector Overview

Presently, India is the largest provider of generic medicines, occupying a market share of 20 percent with respect to global supply by volume and fulfils nearly 60 percent of global demand for vaccines. Indian pharmaceutical stocks even supply nearly 80 percent of antiretroviral drugs (used in combating AIDS) in the international markets.
There are several benefits of investing in pharma stocks:
  • Long-term profitability – Pharma stocks can be attractive to long-term investors in spite of the volatility. The ever rising industry size and healthcare becoming a critical part of life, investors can make good returns if they invest at the right time.
  • Exponential growth – Being the evolving industry that it is, innovation, scientific breakthroughs, and technological advances can bring in exponential growth for many pharma stocks.
×
×
Filter

Top Pharma Companies in India as on May-2024

|
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Syncom Formulations (India) Ltd.
1,277
(Small Cap)
13.58
(1.04%)
54.03
4.62
7.21
10.35
Unlock
2
Morepen Laboratories Ltd.
2,447
(Small Cap)
47.95
(2.28%)
30.12
2.87
19.01
9.18
Unlock
3
Sigachi Industries Ltd.
2,268
(Small Cap)
69.11
(5.00%)
58.59
5.32
23.28
32.58
Unlock
4
KMC Speciality Hospitals (India) Ltd.
1,452
(Small Cap)
89.05
(-0.26%)
N/A
N/A
17.12
31.95
Unlock
5
Suven Life Sciences Ltd.
2,192
(Small Cap)
100.40
(1.26%)
N/A
2.59
-53.54
-163.87
Unlock
6
Bliss GVS Pharma Ltd.
1,156
(Small Cap)
111
(1.32%)
22.83
1.17
14.97
1.73
Unlock
7
Sequent Scientific Ltd.
2,903
(Small Cap)
116.35
(-0.68%)
N/A
4.42
10.88
-288.40
Unlock
8
Panacea Biotec Ltd.
841
(Small Cap)
136.50
(0.18%)
N/A
2.54
-14.85
0.00
Unlock
9
Piramal Pharma Ltd.
19,785
(Small Cap)
149.30
(-0.37%)
50.57
2.95
0.00
0.00
Unlock
10
Marksans Pharma Ltd.
7,559
(Small Cap)
166.90
(-1.33%)
63.75
6.36
17.33
59.01
Unlock
11
Artemis Medicare Services Ltd.
2,627
(Small Cap)
191.40
(0.05%)
53.45
6.84
7.28
17.28
Unlock
12
Dishman Carbogen Amcis Ltd.
3,082
(Small Cap)
197
(-0.56%)
N/A
0.54
7.32
-23.69
Unlock
13
SMS Pharmaceuticals Ltd.
1,741
(Small Cap)
207
(0.15%)
41.88
3.31
2.34
-48.56
Unlock
14
Themis Medicare Ltd.
1,969
(Small Cap)
213.95
(1.74%)
79.57
7.35
11.08
34.06
Unlock
15
Sun Pharma Advanced Research Company Ltd.
7,123
(Small Cap)
219.55
(0.43%)
N/A
30.7
24.99
0.00
Unlock
16
Kopran Ltd.
1,202
(Small Cap)
249.80
(-0.89%)
34.71
2.88
12.18
217.28
Unlock
17
Indraprastha Medical Corporation Ltd.
2,406
(Small Cap)
262
(-0.59%)
19.41
5.03
7.86
31.45
Unlock
18
Shalby Ltd.
3,005
(Small Cap)
273.85
(-0.71%)
30.16
2.89
13.24
14.33
Unlock
19
Sastasundar Ventures Ltd.
944
(Small Cap)
298.25
(2.35%)
N/A
3.46
-100.00
-43.78
Unlock
20
Hikal Ltd.
3,678
(Small Cap)
299.75
(0.57%)
52.85
3.1
9.31
-0.88
Unlock
21
Bajaj Healthcare Ltd.
843
(Small Cap)
304
(-0.62%)
39.64
2.62
18.39
25.96
Unlock
22
Biocon Ltd.
36,582
(Mid Cap)
304.95
(-0.29%)
306.64
3.35
-3.80
31.80
Unlock
23
Indoco Remedies Ltd.
2,970
(Small Cap)
321.05
(0.42%)
25.46
2.64
9.93
28.74
Unlock
24
Gufic Biosciences Ltd.
3,446
(Small Cap)
345.90
(0.30%)
40.93
6.72
17.71
34.15
Unlock
25
Aster DM Healthcare Ltd.
17,376
(Small Cap)
347.85
(-0.47%)
53.61
3.79
12.17
15.37
Unlock
26
Healthcare Global Enterprises Ltd.
5,005
(Small Cap)
359.15
(-1.41%)
125.43
4.22
11.39
7.94
Unlock
27
Jagsonpal Pharmaceuticals Ltd.
955
(Small Cap)
360.85
(0.97%)
38.96
5.33
13.35
0.00
Unlock
28
Blue Jet Healthcare Ltd.
6,384
(Small Cap)
369
(1.85%)
39.9
3.89
0.00
0.00
Unlock
29
Advanced Enzyme Technologies Ltd.
4,196
(Small Cap)
374.10
(0.23%)
38.8
7.23
8.00
9.23
Unlock
30
IOL Chemicals And Pharmaceuticals Ltd.
2,213
(Small Cap)
378.35
(1.12%)
16.46
1.37
0.00
0.00
Unlock
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks 5 Star Rated Stocks Best Nifty 50 Stocks Best Nifty Next 50 Stocks Best Nifty 500 Stocks Best SmallCap Stocks Dividend Opp. Stocks Nifty Financial Services Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Sigachi Industries
69.115%
Zydus Lifesciences
1,104.455%
Concord Biotech
1,493.904.36%
RainbowChildrenS Med
1,3893.64%
Aurobindo Pharma
1,203.903.44%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Shilpa Medicare
499.30-4.38%
Caplin Point Lab
1,313.05-1.90%
HealthcareGlobal
359.15-1.41%
Marksans Pharma
166.90-1.33%
Gland Pharma
1,768.35-1.31%
View More

News about Top Pharma Companies in India

IOL Chemicals and Pharmaceuticals informs about loss of share certificate

Pursuant to Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, IOL Chemicals and Pharmaceuticals has informed that it has received letter regarding loss of share certificate and requesting the Company for issue of duplicate share certificate, from shareholder, as details enclosed.

The above information is a part of company’s filings submitted to BSE.


18 May, 2024

Syncom Formulations - Quaterly Results

A fair growth of 19.39% in the revenue at Rs. 732.66 millions was reported in the March 2024 quarter as compared to Rs. 613.69 millions during year-ago period.A slender decline of -20.30% was recorded to Rs. 67.47  millions from Rs. 84.66 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 116.75 millions from 127.17 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 732.66 613.69 19.39 2583.60 2246.44 15.01 2583.60 2246.44 15.01
Other Income 28.71 67.79 -57.65 131.01 146.10 -10.33 131.01 146.10 -10.33
PBIDT 116.75 127.17 -8.19 409.55 342.22 19.67 409.55 342.22 19.67
Interest 11.70 12.92 -9.44 44.49 31.30 42.14 44.49 31.30 42.14
PBDT 105.05 114.38 -8.16 364.82 311.05 17.29 364.82 311.05 17.29
Depreciation 12.98 11.68 11.13 47.22 45.39 4.03 47.22 45.39 4.03
PBT 92.07 102.70 -10.35 317.60 265.66 19.55 317.60 265.66 19.55
TAX 24.60 18.04 36.36 81.36 64.95 25.27 81.36 64.95 25.27
Deferred Tax 0.43 -7.84 -105.48 5.54 -1.53 -462.09 5.54 -1.53 -462.09
PAT 67.47 84.66 -20.30 236.24 200.71 17.70 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.94 20.72 -23.10 15.85 15.23 4.06 15.85 15.23 4.06
17 May, 2024

Biocon rises despite reporting 46% fall in Q4 consolidated net profit

Total consolidated income of the company increased by 0.94% at Rs 3965.70 crore for Q4FY24
17 May, 2024

Indraprastha Medical - Quaterly Results

The Revenue for the quarter ended  March 2024 of Rs. 3147.30 millions grew by 14.84 % from Rs. 2740.50 millions.Profit after tax for the quarter ended March 2024 reported a huge growth of 57.11% to Rs. 311.70  millions from Rs. 198.40 millions.OP of the company witnessed a marginal growth to 533.30 millions from 379.30 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3147.30 2740.50 14.84 12447.00 10986.70 13.29 12447.00 10986.70 13.29
Other Income 48.90 47.90 2.09 168.90 100.30 68.39 168.90 100.30 68.39
PBIDT 533.30 379.30 40.60 2102.50 1607.30 30.81 2102.50 1607.30 30.81
Interest 15.60 8.70 79.31 40.60 42.80 -5.14 40.60 42.80 -5.14
PBDT 517.70 370.60 39.69 2061.90 1564.50 31.79 2061.90 1564.50 31.79
Depreciation 102.10 98.60 3.55 400.80 392.70 2.06 400.80 392.70 2.06
PBT 415.60 272.00 52.79 1661.10 1171.80 41.76 1661.10 1171.80 41.76
TAX 103.90 73.60 41.17 421.50 310.30 35.84 421.50 310.30 35.84
Deferred Tax 12.20 40.90 -70.17 -8.80 -1.10 700.00 -8.80 -1.10 700.00
PAT 311.70 198.40 57.11 1239.60 861.50 43.89 1239.60 861.50 43.89
Equity 916.70 916.70 0.00 916.70 916.70 0.00 916.70 916.70 0.00
PBIDTM(%) 16.94 13.84 22.43 16.89 14.63 15.46 16.89 14.63 15.46
17 May, 2024

Indraprastha Medical - Quaterly Results

The March 2024 quarter revenue stood at Rs. 3147.30 millions, up 14.84% as compared to Rs. 2740.50 millions during the corresponding quarter last year.Net profit surges 57.11% to Rs. 311.70  millions  from Rs. 198.40 millions in the quarter ended March 2024.The company reported a good operating profit of 533.30 millions compared to 379.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 3147.30 2740.50 14.84 12447.00 10986.70 13.29 12447.00 10986.70 13.29
Other Income 48.90 47.90 2.09 168.90 100.30 68.39 168.90 100.30 68.39
PBIDT 533.30 379.30 40.60 2102.50 1607.30 30.81 2102.50 1607.30 30.81
Interest 15.60 8.70 79.31 40.60 42.80 -5.14 40.60 42.80 -5.14
PBDT 517.70 370.60 39.69 2061.90 1564.50 31.79 2061.90 1564.50 31.79
Depreciation 102.10 98.60 3.55 400.80 392.70 2.06 400.80 392.70 2.06
PBT 415.60 272.00 52.79 1661.10 1171.80 41.76 1661.10 1171.80 41.76
TAX 103.90 73.60 41.17 421.50 310.30 35.84 421.50 310.30 35.84
Deferred Tax 12.20 40.90 -70.17 -8.80 -1.10 700.00 -8.80 -1.10 700.00
PAT 311.70 198.40 57.11 1239.60 861.50 43.89 1239.60 861.50 43.89
Equity 916.70 916.70 0.00 916.70 916.70 0.00 916.70 916.70 0.00
PBIDTM(%) 16.94 13.84 22.43 16.89 14.63 15.46 16.89 14.63 15.46
17 May, 2024

Themis Medicare informs about newspaper advertisement

In terms of Regulations 47 of SEBI(LODR) Regulations, 2015 the Company has published the Audited Financial Results for the quarter and year ended 31st March,2024 in 'Indian Express' (English) edition and in Financials Express' (Gujarati) edition on Thursday, 16th May, 2024. Further, in pursuance of Regulation 30 read with Schedule III (A) (12), Themis Medicare has informed that it enclosed the copy of Newspaper articles as published in the above-mentioned newspapers.

The above information is a part of company’s filings submitted to BSE.

17 May, 2024

Track Now: 5 Star Companies, Large Cap Companies, Mid Cap Companies, Small Cap Companies, Nifty Microcap Companies, Top IT Companies, Tax saver funds, Analyze your Equity Funds, Nifty Index Funds

Trending on MoneyWorks4Me: Stock Reasearch Reports, How many stocks to own in portfolio?, Why PE Ratio is important?, How to Choose Good Stocks?, Types of Mutual Funds, Why funds future upside is more useful than past performance?

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2024.
Rank Company Market Capitalization 2024 (INR  crores)
1 Syncom Formulations (India) Ltd. 1,277 Crore
2 Morepen Laboratories Ltd. 2,447 Crore
3 Sigachi Industries Ltd. 2,268 Crore
4 KMC Speciality Hospitals (India) Ltd. 1,452 Crore
5 Suven Life Sciences Ltd. 2,192 Crore
6 Bliss GVS Pharma Ltd. 1,156 Crore
7 Sequent Scientific Ltd. 2,903 Crore
8 Panacea Biotec Ltd. 841 Crore
9 Piramal Pharma Ltd. 19,785 Crore
10 Marksans Pharma Ltd. 7,559 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Sanofi India Ltd. (S) Very Good 8,821 20,331 37.01 18.76 23.75 51.69
Abbott India Ltd. (M) Very Good 26,618 56,616 47.13 15.31 32.02 31.69
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 21.71
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 20.88
Torrent Pharmaceuticals Ltd. (L) Very Good 2,699 91,556 61.28 12.80 29.38 20.23

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Zydus Lifesciences Ltd. (L) Very Good 1,104 1,11,134 117.7
Lupin Ltd. (M) Somewhat Good 1,662 75,652 113.0
Aurobindo Pharma Ltd. (M) Very Good 1,204 70,468 100.7
Ipca Laboratories Ltd. (M) Very Good 1,311 33,258 94.25
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 82.76
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 24.05
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 19.01
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 18.11
Gland Pharma Ltd. (M) Very Good 1,768 29,304 36.58 3.38 20.84 17.42
Mankind Pharma Ltd. (L) Very Good 2,115 84,596 46.39 8.79 32.35 15.71

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Laurus Labs Ltd. (S) Very Good 443.6 23,957 149.2 5.83 32.75 38.61
Dr. Reddys Laboratories Ltd. (L) Very Good 5,813 97,001 17.39 3.43 10.98 36.08
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,835 28,566 52.57 9.90 31.56 31.92
Biocon Ltd. (M) Somewhat Good 304.9 36,582 306.6 3.35 83.47 31.80
Granules India Ltd. (S) Somewhat Good 405.5 9,856 22.61 3.17 13.23 31.51
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
Compliance Officer:
Name: Shrikant Jagtap
Email : shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance officer:
Name: Mukta Vaze
Email : mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email : atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
Sitemap play-store Download APP play-store Download APP
linkedin facebook twitter youtube insta telegram
Address: MoneyWorks4Me Investment Advisers, B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Register a Complaint | Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | Investor charter | Terms & Conditions | Disclaimer | Disclosure
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.